- The effect of nucleos(t)ide analogues on clinical outcomes of patients treated with transarterial chemoembolization and radiofrequency ablation for hepatitis B virus-related hepatocellular carcinoma
-
Park JM, Choe WH, Kim JH, Kwon SY, Yoo BC
- KMID: 2520902
- J Liver Cancer.
- 2021 Sep;21(2):155-162.
- doi: 10.17998/jlc.2021.09.22
Background/Aims: Because hepatitis B virus (HBV) replication has been known to play an important role in cancer recurrence after curative treatment of HBV-related hepatocellular carcinoma (HCC), we examined whether treatment based on... -
- CITED
-
- Close
- SHARE
-
- Close
- Seroreversion and Acute Decompensation in Chronic Hepatitis B after Discontinuation of Oral Nucleotide Analog in the Patients Achieving HBsAg Loss
-
Cho HJ, Shin SK, Kwon OS, Kim JH, Kim YS
- KMID: 2508876
- Korean J Gastroenterol.
- 2020 Nov;76(5):256-260.
- doi: 10.4166/kjg.2020.111
Although rare patients with chronic hepatitis B can achieve HBsAg loss on oral nucleos(t)ide analog (NA), the optimal timing of stopping oral NAs safely has been considered when HBsAg and... -
- CITED
-
- Close
- SHARE
-
- Close
- Nucleos(t)ide Analogues for Reducing Hepatocellular Carcinoma in Chronic Hepatitis B Patients: A Systematic Review and Meta-Analysis
-
Wang X, Liu X, Dang Z, Yu L, Jiang Y, Wang X, Yang Z
- KMID: 2508758
- Gut Liver.
- 2020 Mar;14(2):232-247.
- doi: 10.5009/gnl18546
Background/Aims: Studies have shown that nucleos(t)ide analogue (NA) treatment can reduce the risk of hepatocellular carcinoma (HCC) in chronic hepatitis B (CHB) patients, but it is unclear which NA is... -
- CITED
-
- Close
- SHARE
-
- Close
- Lamivudine: fading into the mists of time
-
Choi J, Lim YS
- KMID: 2406039
- Clin Mol Hepatol.
- 2017 Dec;23(4):314-315.
- doi: 10.3350/cmh.2017.0110
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- The mechanism and treatment of anti-viral resistant hepatitis B virus
-
Song BC
- KMID: 2259133
- Korean J Med.
- 2010 May;78(5):564-574.
Even though substantial advances have been made in the treatment of chronic hepatitis B in the past decade with the use of oral nucleos(t)ide analogues (NAs), emergence of anti-viral resistance... -
- CITED
-
- Close
- SHARE
-
- Close
